Tai, W.; Chow, M.Y.T.; Chang, R.Y.K.; Tang, P.; Gonda, I.; MacArthur, R.B.; Chan, H.-K.; Kwok, P.C.L.
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19. Pharmaceutics 2021, 13, 1260.
https://doi.org/10.3390/pharmaceutics13081260
AMA Style
Tai W, Chow MYT, Chang RYK, Tang P, Gonda I, MacArthur RB, Chan H-K, Kwok PCL.
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19. Pharmaceutics. 2021; 13(8):1260.
https://doi.org/10.3390/pharmaceutics13081260
Chicago/Turabian Style
Tai, Waiting, Michael Yee Tak Chow, Rachel Yoon Kyung Chang, Patricia Tang, Igor Gonda, Robert B. MacArthur, Hak-Kim Chan, and Philip Chi Lip Kwok.
2021. "Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19" Pharmaceutics 13, no. 8: 1260.
https://doi.org/10.3390/pharmaceutics13081260
APA Style
Tai, W., Chow, M. Y. T., Chang, R. Y. K., Tang, P., Gonda, I., MacArthur, R. B., Chan, H.-K., & Kwok, P. C. L.
(2021). Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19. Pharmaceutics, 13(8), 1260.
https://doi.org/10.3390/pharmaceutics13081260